Fennec Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOUTHPOINT CAPITAL ADVISORS LP | 02/17/2026 | 2.74 M | $21.13 M | -32.68% | 9.84% |
| ROSALIND ADVISORS, INC. | 02/12/2026 | 2.61 M | $20.12 M | 25.84% | 9.37% |
| SOLAS CAPITAL MANAGEMENT, LLC | 02/17/2026 | 2.56 M | $19.72 M | 17.04% | 9.18% |
| AIGH CAPITAL MANAGEMENT LLC | 02/02/2026 | 1.58 M | $12.18 M | 132.06% | 5.67% |
| BLACKROCK, INC. | 02/12/2026 | 1.23 M | $9.50 M | 1.85% | 4.43% |
| VANGUARD GROUP INC | 01/29/2026 | 1.07 M | $8.22 M | 11.71% | 3.83% |
| AWM INVESTMENT COMPANY, INC. | 02/13/2026 | 711.87 K | $5.48 M | 100.00% | 2.55% |
| STATE STREET CORP | 02/13/2026 | 352.78 K | $2.72 M | 3.39% | 1.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 297.10 K | $2.29 M | -1.22% | 1.07% |
| MORGAN STANLEY | 02/13/2026 | 242.48 K | $1.87 M | 4.33% | 0.87% |
| APIS CAPITAL ADVISORS, LLC | 02/17/2026 | 204.00 K | $1.57 M | 100.00% | 0.73% |
| CITADEL ADVISORS LLC | 02/17/2026 | 199.75 K | $1.54 M | 85.82% | 0.72% |
| GENDELL JEFFREY L | 02/13/2026 | 139.56 K | $1.07 M | 0.00% | 0.50% |
| MARSHALL WACE, LLP | 02/13/2026 | 127.69 K | $983.24 K | 100.00% | 0.46% |
| LION POINT CAPITAL, LP | 02/17/2026 | 112.43 K | $865.74 K | -8.59% | 0.40% |
| NORTHERN TRUST CORP | 02/17/2026 | 112.09 K | $863.11 K | -14.14% | 0.40% |
| POTOMAC CAPITAL MANAGEMENT, INC. | 02/11/2026 | 95.10 K | $732.27 K | 100.00% | 0.34% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 83.01 K | $639.14 K | 170.37% | 0.30% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 57.25 K | $440.82 K | 0.00% | 0.21% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 51.38 K | $395.63 K | 100.00% | 0.18% |
| STATE OF WISCONSIN INVESTMENT BOARD | 02/17/2026 | 51.00 K | $392.70 K | 58.88% | 0.18% |
| HARTFORD FINANCIAL MANAGEMENT INC. | 01/21/2026 | 50.65 K | $389.98 K | 0.00% | 0.18% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 50.00 K | $385.00 K | 100.00% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 49.22 K | $378.99 K | -5.85% | 0.18% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 44.69 K | $344.13 K | 100.00% | 0.16% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 02/10/2026 | 44.00 K | $338.80 K | 100.00% | 0.16% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 43.59 K | $335.64 K | 64.55% | 0.16% |
| BARCLAYS PLC | 02/13/2026 | 36.60 K | $281.80 K | 10.77% | 0.13% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 32.46 K | $249.94 K | 19.98% | 0.12% |
| RHUMBLINE ADVISERS | 02/13/2026 | 29.04 K | $223.59 K | -13.38% | 0.10% |
| 1492 CAPITAL MANAGEMENT LLC | 02/10/2026 | 28.09 K | $216.31 K | 100.00% | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 27.06 K | $207.00 K | 152.70% | 0.10% |
| XTX TOPCO LTD | 02/17/2026 | 26.79 K | $206.25 K | 26.07% | 0.10% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 26.16 K | $201.42 K | 53.74% | 0.09% |
| NUVEEN, LLC | 02/12/2026 | 26.01 K | $200.25 K | 0.00% | 0.09% |
| JONES FINANCIAL COMPANIES LLLP | 02/17/2026 | 24.95 K | $192.13 K | 165.45% | 0.09% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 24.40 K | $187.90 K | 102.05% | 0.09% |
| JANE STREET GROUP, LLC | 02/12/2026 | 24.04 K | $185.14 K | -66.90% | 0.09% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 22.53 K | $173.50 K | 67.62% | 0.08% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 21.30 K | $164.00 K | 100.00% | 0.08% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 20.00 K | $154.00 K | 88.68% | 0.07% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 17.37 K | $133.71 K | 100.00% | 0.06% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 15.14 K | $116.57 K | 0.85% | 0.05% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 15.00 K | $115.50 K | 0.00% | 0.05% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 14.76 K | $113.66 K | -3.66% | 0.05% |
| INVESCO LTD. | 02/19/2026 | 14.33 K | $110.33 K | 18.15% | 0.05% |
| LAZARD ASSET MANAGEMENT LLC | 02/17/2026 | 13.12 K | $101.03 K | 100.00% | 0.05% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 13.11 K | $100.94 K | 100.00% | 0.05% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/12/2026 | 13.02 K | $100.25 K | 35.71% | 0.05% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 13.00 K | $100.10 K | 100.00% | 0.05% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Fennec Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 121 institutional investors and hedge funds held shares of Fennec Pharmaceuticals Inc. The most heavily invested institutionals were:
AIGH Capital Management LLC: 1.98 M
Cornerstone Capital, Inc.: 105,000
Nuveen, LLC: 60,948
THOMPSON SIEGEL & WALMSLEY LLC: 57,226
Eleva Capital SAS: 53,234
Bank of New York Mellon Corp: 52,462
55.72% of Fennec Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 23.19 M shares in the last 24 months. This purchase volume represents approximately $176.03 M in transactions.